Page last updated: 2024-10-18

dihydroxyphenylalanine and Hyperkalemia

dihydroxyphenylalanine has been researched along with Hyperkalemia in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kruse, H1

Other Studies

1 other study available for dihydroxyphenylalanine and Hyperkalemia

ArticleYear
[APUD mechanisms in different functional states of C-cells].
    Endokrinologie, 1971, Volume: 57, Issue:2

    Topics: Animals; Calcitonin; Cautery; Dihydroxyphenylalanine; Hyperkalemia; Microscopy, Electron; Microscopy

1971